Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Introduction
00:00 • 3min
The FDA Appropriation of Agile Home - What We Learned
02:37 • 3min
Drug Pricing and the Trust in the Drug Industry
05:28 • 2min
Are There Any Real Consequences to This Report for FDA or Biogen?
07:31 • 2min
Do You Think the FDA Will Approve Yet Another Alzheimer's Drug?
09:13 • 3min
ESI vs Biogen - What's the Difference?
12:42 • 2min
Is the Canon Mab a Non-Existing Drug?
14:19 • 3min
Alzheimer's Drugs - What Should I Be Concerned About?
17:24 • 2min
Is Lacanima Going to Be That?
19:29 • 3min
Biogen CEO Interview
22:21 • 3min
What's the Vibe of the JP Morgan Healthcare Conference?
25:36 • 2min
COVID - Do You Think It Will Make a Difference?
27:26 • 2min
COVID in China - What's Going On?
29:10 • 3min
The Most Important Catalyst for This Quarter
31:42 • 4min